BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 34789125)

  • 1. The Pandemic of Coronavirus Disease 2019 (COVID-19).
    Rashid NN
    Curr Mol Med; 2022; 22(9):761-765. PubMed ID: 34789125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention.
    Sharma A; Ahmad Farouk I; Lal SK
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33572857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronicling the 3-year evolution of the COVID-19 pandemic: analysis of disease management, characteristics of major variants, and impacts on pathogenicity.
    Pitsillou E; Yu Y; Beh RC; Liang JJ; Hung A; Karagiannis TC
    Clin Exp Med; 2023 Nov; 23(7):3277-3298. PubMed ID: 37615803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Virology of SARS-CoV-2 and Related Coronaviruses.
    Kung YA; Lee KM; Chiang HJ; Huang SY; Wu CJ; Shih SR
    Microbiol Mol Biol Rev; 2022 Jun; 86(2):e0002621. PubMed ID: 35343760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Different Perspective on the COVID-19 Pandemic: Origin of the Outbreak (Part 1).
    Barbari A
    Exp Clin Transplant; 2024 Jan; 22(Suppl 2):1-14. PubMed ID: 38385593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies.
    Daemi HB; Kulyar MF; He X; Li C; Karimpour M; Sun X; Zou Z; Jin M
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34203647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The find of COVID-19 vaccine: Challenges and opportunities.
    ElBagoury M; Tolba MM; Nasser HA; Jabbar A; Elagouz AM; Aktham Y; Hutchinson A
    J Infect Public Health; 2021 Mar; 14(3):389-416. PubMed ID: 33647555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus: Update Related to the Current Outbreak of COVID-19.
    Gabutti G; d'Anchera E; Sandri F; Savio M; Stefanati A
    Infect Dis Ther; 2020 Jun; 9(2):241-253. PubMed ID: 32292686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines.
    Hillary VE; Ceasar SA
    Heliyon; 2023 Mar; 9(3):e13952. PubMed ID: 36855648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 in Human, Animal, and Environment: A Review.
    Swelum AA; Shafi ME; Albaqami NM; El-Saadony MT; Elsify A; Abdo M; Taha AE; Abdel-Moneim AE; Al-Gabri NA; Almaiman AA; Saleh Al-Wajeeh A; Tufarelli V; Staffa VN; Abd El-Hack ME
    Front Vet Sci; 2020; 7():578. PubMed ID: 33102545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2.
    Valencia DN
    Cureus; 2020 Mar; 12(3):e7386. PubMed ID: 32337113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rationale for a multi-step therapeutic approach based on antivirals, drugs and nutrients with immunomodulatory activity in patients with coronavirus-SARS2-induced disease of different severities.
    Fiorino S; Zippi M; Gallo C; Sifo D; Sabbatani S; Manfredi R; Rasciti E; Rasciti L; Giampieri E; Corazza I; Leandri P; de Biase D
    Br J Nutr; 2021 Feb; 125(3):275-293. PubMed ID: 32703328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reflections on the Global Pandemic of COVID-19 and the Response Strategies].
    Lu Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Nov; 52(6):936-938. PubMed ID: 34841757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Natural Products Against Respiratory Viruses: A Perspective to Develop Anti-COVID-19 Medicines.
    Omrani M; Keshavarz M; Nejad Ebrahimi S; Mehrabi M; McGaw LJ; Ali Abdalla M; Mehrbod P
    Front Pharmacol; 2020; 11():586993. PubMed ID: 33679384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: comprehensive review on mutations and current vaccines.
    Hebbani AV; Pulakuntla S; Pannuru P; Aramgam S; Badri KR; Reddy VD
    Arch Microbiol; 2021 Dec; 204(1):8. PubMed ID: 34873656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-CoV-2 Infection.
    Vittoria BL; Imbesi C; Irene G; Calì G; Bitto A
    Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34070359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 immunity in animal models.
    Chen Z; Yuan Y; Hu Q; Zhu A; Chen F; Li S; Guan X; Lv C; Tang T; He Y; Cheng J; Zheng J; Hu X; Zhao J; Zhao J; Sun J
    Cell Mol Immunol; 2024 Feb; 21(2):119-133. PubMed ID: 38238440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive review of COVID-19 characteristics.
    Esakandari H; Nabi-Afjadi M; Fakkari-Afjadi J; Farahmandian N; Miresmaeili SM; Bahreini E
    Biol Proced Online; 2020; 22():19. PubMed ID: 32774178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus disease 2019 in children.
    Levy ER; Blumenthal J; Chiotos K
    Curr Opin Infect Dis; 2021 Oct; 34(5):500-509. PubMed ID: 34261902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options.
    Beig Parikhani A; Bazaz M; Bamehr H; Fereshteh S; Amiri S; Salehi-Vaziri M; Arashkia A; Azadmanesh K
    Curr Microbiol; 2021 Apr; 78(4):1099-1114. PubMed ID: 33638671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.